Studies

Vitamin C Study

Abstract

When comparing a “normal” Vitamin C ingestion (dose of 4g) to a Liposomal Vitamin C (also 4g), it’s evident that our CELLg8® Liposomal Delivery System provides much greater circulating Vitamin C concentrations. With increased efficacy, oxidative stress was reduced even during the increased oxidative stress of reperfusion, resulting in meaningful Vitamin C concentration. As CELLg8® has entered the 8th and final generation, our Liposomal Vitamin C had a peak particle size of 8nm, with 92% of the particles being between 60 and 172nm. This tight distribution is indicative of the reproducible and highly controlled manufacturing methodology of CELLg8® Liposomes.

Vitamin B12 Study

Abstract

A single-dose, crossover study was conducted in six human subjects of equivalent doses of two dosage forms of vitamin B12 – a standard liposomal liquid and a liposomal powder-filled capsule (using CELLg8 technology). Each subject was given 3 mg of vitamin B12 in one dosage form, followed by a washout period of 14 days, then dosing with the other dosage form.

All subjects (with one exception) had an increase above baseline at one or more time points over 135 minutes. Serum B12 increased six-fold on average after taking the CELLg8 liposomal capsule compared to the traditional liposomal liquid when comparing the highest peak of each subject’s serum B12.

Green Tea Study

Abstract

A single centre, non-randomised, blind crossover study involving 26 participants was conducted by the PCDDP at the North-West University in South Africa. The purpose of the study was to assess the bio-availability of the green tea extract used in the production of Origine 8™ compared to a standard commercially available extract of green tea commonly found in green tea supplements.

Participants consumed 200mg twice per day of a standard green tea extract followed by a 14 day washout period and thereafter 200mg twice per day dose of the extract found in Origine 8™ was consumed. Blood samples were drawn over a 24 hour period post consumption to measure levels of catechin concentrations in the blood.

Hemp Safety Study

Abstract

A human clinical safety study examined the alterations in the blood profiles of 10 healthy adults before and after taking CELLg8™ Hemp—an advanced liposomal cannabinoid preparation standardized for cannabidiol—daily for 30 days. Primary outcome measures were the comprehensive metabolic panel and complete blood count. Results showed that of 340 blood tests administered, 339 improved or remained the same at day 30. One patient showed an increase in absolute eosinophil or neutrophil count from 319 to 573 cells/µL (normal range, 15-500 cells/µL). Furthermore, all 5 individuals who had high glucose levels at baseline showed normal levels on day 30 of liposomal cannabidiol treatment. In conclusion, this study demonstrated the safety of CELLg8™ Hemp and the potential efficacy of this preparation to lower fasting blood glucose levels.

Hemp Absorption

Abstract

OBJECTIVE: The aim of this study was to measure the bioavailability of equivalent amounts of cannabidiol (CBD, 10 mg) as a stand-alone active ingredient compared with a liposomal preparation (CELLg8® Hemp).

METHODS: This pharmacokinetic pilot study included 15 healthy patients who were not taking a CBD product at baseline. A crossover study design was used to analyze peak blood CBD levels at baseline and 1 hour after ingesting the liposomal and nonliposomal preparations, with a 2-week washout period between each preparation.

RESULTS: CBD was detected in the blood of all 15 patients who ingested the liposomal preparation at 1 hour, whereas the stand-alone ingredient was only found in 40% of the individuals at the same time point. Serum levels of CBD were significantly higher (P<0.0001) in patients after use of the liposomal preparation compared with the stand-alone CBD.

CONCLUSION: The findings suggest that the bioavailability of oral CBD is higher in the liposomal preparation than the nonliposomal CBD preparation.

The CELLg8® Science

CELLg8® is a nutrient delivery system that has been clinically proven through safety, absorption, and blood glucose studies to enhance the absorption of most vitamins, minerals, and herbs.
  • 100% natural process. No heat. No pressure. No chemicals.
  • Backed by clinical studies and published papers.
  • All the benefits without any of the side effects.
  • CELLg8® Technology can be applied to most vitamins, minerals, and herbs.
  • Safety remains our #1 priority; We continually invest in ongoing clinical studies.

Understanding CELLg8® Liposomes

CELLg8 has developed industry-leading liposomal technology over the last 20+ years. In this time, CELLg8® has been through 8 generations and is now in its final iteration. CELLg8® Liposomes have been clinically proven to have better absorption, increased efficacy, and no side effects. We currently have multiple ongoing clinical studies to further prove the effectiveness & safety of CELLg8® Technology.

Learn More

View More Information